Mutual funds buy Reliance, Swiggy and Gland Pharma in September
In short
Mutual funds bought shares worth thousands of crores in September 2026. Reliance Industries, Swiggy and Gland Pharma were among the biggest buys across large, mid and small companies.
This matters because big fund buying can support stock prices and show where managers see value. The report does not give the exact amount for each stock in the summary.
What the reporting says
Mutual funds bought shares worth thousands of crores in September 2026, led by Reliance Industries, Swiggy and Gland Pharma across large-, mid- and small-cap categories, according to the publisher summary. The report says the rankings come from Value Research. The immediate implication is stronger institutional demand for these stocks, but the source does not give the exact amounts for each name in the summary provided.
Why it matters
Mutual funds bought shares worth thousands of crores in September 2026, with Reliance Industries, Swiggy and Gland Pharma leading purchases across market-cap buckets, according to the publisher summary. The report cites Value Research but does not provide the exact stock-wise amounts in the material supplied. The event points to continued institutional allocation into select Indian equities.